These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 23645739)

  • 1. Expression of bone morphogenetic protein-10 (BMP10) in human urothelial cancer of the bladder and its effects on the aggressiveness of bladder cancer cells in vitro.
    Zhang N; Ye L; Wu L; Deng X; Yang Y; Jiang WG
    Anticancer Res; 2013 May; 33(5):1917-25. PubMed ID: 23645739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of vascular endothelial growth inhibitor (VEGI) in human urothelial cancer of the bladder and its effects on the adhesion and migration of bladder cancer cells in vitro.
    Zhang N; Sanders AJ; Ye L; Kynaston HG; Jiang WG
    Anticancer Res; 2010 Jan; 30(1):87-95. PubMed ID: 20150621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual role of TGFBR3 in bladder cancer.
    Liu XL; Xiao K; Xue B; Yang D; Lei Z; Shan Y; Zhang HT
    Oncol Rep; 2013 Sep; 30(3):1301-8. PubMed ID: 23835618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth differentiation factor-9 expression is inversely correlated with an aggressive behaviour in human bladder cancer cells.
    Du P; Ye L; Li H; Ruge F; Yang Y; Jiang WG
    Int J Mol Med; 2012 Mar; 29(3):428-34. PubMed ID: 22159313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metastasis suppressor-1, MTSS1, acts as a putative tumour suppressor in human bladder cancer.
    Du P; Ye L; Ruge F; Yang Y; Jiang WG
    Anticancer Res; 2011 Oct; 31(10):3205-12. PubMed ID: 21965727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer.
    Feeley BT; Gamradt SC; Hsu WK; Liu N; Krenek L; Robbins P; Huard J; Lieberman JR
    J Bone Miner Res; 2005 Dec; 20(12):2189-99. PubMed ID: 16294272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of EphA2 and Ephrin A-1 in carcinoma of the urinary bladder.
    Abraham S; Knapp DW; Cheng L; Snyder PW; Mittal SK; Bangari DS; Kinch M; Wu L; Dhariwal J; Mohammed SI
    Clin Cancer Res; 2006 Jan; 12(2):353-60. PubMed ID: 16428472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inducing cell proliferation inhibition, apoptosis, and motility reduction by silencing long noncoding ribonucleic acid metastasis-associated lung adenocarcinoma transcript 1 in urothelial carcinoma of the bladder.
    Han Y; Liu Y; Nie L; Gui Y; Cai Z
    Urology; 2013 Jan; 81(1):209.e1-7. PubMed ID: 23153939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The tumour suppressive role of metastasis suppressor-1, MTSS1, in human kidney cancer, a possible connection with the SHH pathway.
    Du P; Ye L; Li H; Yang Y; Jiang WG
    J Exp Ther Oncol; 2012; 10(2):91-9. PubMed ID: 23350348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Claudin-11 decreases the invasiveness of bladder cancer cells.
    Awsare NS; Martin TA; Haynes MD; Matthews PN; Jiang WG
    Oncol Rep; 2011 Jun; 25(6):1503-9. PubMed ID: 21468549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inducing cell proliferation inhibition and apoptosis via silencing Dicer, Drosha, and Exportin 5 in urothelial carcinoma of the bladder.
    Han Y; Liu Y; Gui Y; Cai Z
    J Surg Oncol; 2013 Feb; 107(2):201-5. PubMed ID: 22766726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of immunoglobulin G prompts cell proliferation and inhibits cell apoptosis in human urothelial carcinoma.
    Liang PY; Li HY; Zhou ZY; Jin YX; Wang SX; Peng XH; Ou SJ
    Tumour Biol; 2013 Jun; 34(3):1783-91. PubMed ID: 23483488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bufalin prevents the migration and invasion of T24 bladder carcinoma cells through the inactivation of matrix metalloproteinases and modulation of tight junctions.
    Hong SH; Kim GY; Chang YC; Moon SK; Kim WJ; Choi YH
    Int J Oncol; 2013 Jan; 42(1):277-86. PubMed ID: 23128598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Livin may serve as a marker for prognosis of bladder cancer relapse and a target of bladder cancer treatment.
    Liu HB; Kong CZ; Zeng Y; Liu XK; Bi JB; Jiang YJ; Han S
    Urol Oncol; 2009; 27(3):277-83. PubMed ID: 18555709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of thymosin β4 in the regulation of epithelial-mesenchymal transformation in urothelial carcinoma.
    Wang ZY; Zeng FQ; Zhu ZH; Jiang GS; Lv L; Wan F; Dong R; Xiao XY; Xing SA
    Urol Oncol; 2012; 30(2):167-76. PubMed ID: 20864366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of HIF-1α in a novel optical orthotopic spontaneous metastatic bladder cancer animal model.
    Zhang T; Fan J; Wu K; Zeng J; Sun K; Guan Z; Wang X; Hiesh JT; He D
    Urol Oncol; 2012; 30(6):928-35. PubMed ID: 22341926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of YC-1 on hypoxia-inducible factor 1 alpha in hypoxic human bladder transitional carcinoma cell line T24 cells.
    Li Y; Zhao X; Tang H; Zhong Z; Zhang L; Xu R; Li S; Wang Y
    Urol Int; 2012; 88(1):95-101. PubMed ID: 22041818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of expression of growth differentiation factor-9 (GDF9) in human kidney cancer and regulation of growth and migration of kidney cancer cells by GDF9.
    Du P; Ye L; Li H; Ruge F; Yang Y; Jiang WG
    Anticancer Res; 2012 Oct; 32(10):4375-83. PubMed ID: 23060562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA interference suppressing PLCE1 gene expression decreases invasive power of human bladder cancer T24 cell line.
    Ou L; Guo Y; Luo C; Wu X; Zhao Y; Cai X
    Cancer Genet Cytogenet; 2010 Jul; 200(2):110-9. PubMed ID: 20620593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restoration of bone morphogenetic protein receptor type II expression leads to a decreased rate of tumor growth in bladder transitional cell carcinoma cell line TSU-Pr1.
    Kim IY; Lee DH; Lee DK; Kim WJ; Kim MM; Morton RA; Lerner SP; Kim SJ
    Cancer Res; 2004 Oct; 64(20):7355-60. PubMed ID: 15492256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.